Sold as Moduretic 5-50. Every FDA application for this active ingredient: 1 branded and 6 generic. Boxed warning
As of Nov 22, 2026, FDA lists 7 applications for Amiloride hydrochloride; Hydrochlorothiazide (sold as Moduretic 5-50), first approved Oct 5, 1981, with 0 new uses approved and 0 published complete response letters.
| Oct 5, 1981 | Moduretic 5-50NDA 18201 · New combination | Merck & Co. (MSD) | 37 | Discontinued |
| Aug 6, 1986 | Hydro-RideANDA 70347 | Par Pharmaceutical | 8 | Discontinued |
| Jul 15, 1987 | Amiloride Hydrochloride and HydrochlorothiazideANDA 70795 | Teva Pharmaceutical Industries | 16 | Discontinued |
| May 10, 1988 | Amiloride Hydrochloride and HydrochlorothiazideANDA 71111 | Barr Laboratories | 21 | Marketed |
| Jul 19, 1991 | Amiloride Hydrochloride and HydrochlorothiazideANDA 73334 | Watson Laboratories | 12 | Discontinued |
| Oct 31, 1991 | Amiloride Hydrochloride and HydrochlorothiazideANDA 73209 | Rising Pharmaceuticals | 9 | Marketed |
| Nov 27, 1991 | Amiloride Hydrochloride and HydrochlorothiazideANDA 73357 | Chartwell RX | 9 | Discontinued |
| Study | Phase | Status | Posted |
|---|---|---|---|
| Vertebrobasilar Dolichoectasia Treatment With AmilorideVertebrobasilar Dolichoectasia · Huashan Hospital | Phase 2 | Not yet recruiting | Jun 8, 2026 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Mechanisms, targets, withdrawals and boxed warnings are from ChEMBL (EMBL-EBI, CC BY-SA 3.0), matched by ingredient name. How trials ended is TrialPanorama's classification of ClinicalTrials.gov records (Wang et al. 2025, Apache-2.0), matched by the intervention name each trial registered. Drugs@FDA